Number of Patients
All patients currently enrolled in the PRAETORIAN trial will be approached for an extended follow-up duration of 48 additional months.
Duration of the Study
The follow-up duration of the original study will be extended with an additional 48 month, starting in December 2019. The study is expected to be complete in 2023.
All centers who were active in the PRAETORIAN trial will be approached to prolong their participation. All centers have qualified cardiology departments with facilities for ICD implantation and have ample experience with both TV- and S-ICD devices.